Lucid Diagnostics

PriceLucid Diagnostics

LUCD

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Historical stock price chart and annual return over the past years

-87%

3 years

% Total

LUCD
-40%

3 years

Annual Return

LUCD